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Honey bee stings are an occupational hazard for beekeepers and
often lead to allergic reactions. Furthermore, approximately 40% of
Japanese forestry workers have speciﬁc (s) immunoglobulin (Ig) E
to Hymenoptera venom.1 Recently, we reported that around
6e33% of Japanese outdoor workers (forestry workers, building
contractors, and electrical facility ﬁeld workers) with sIgE positivity
to Hymenoptera venom received prescriptions for adrenaline auto-
injectors.2 Only 23e57% of such workers who had experienced sys-
temic reactions to a Hymenoptera sting with a positive result of
sIgE to Hymenoptera venom had been prescribed adrenaline
auto-injectors.2 However, honey bee stings and the prescribing of
adrenaline auto-injectors for affected workers have not been sur-
veyed in occupational settings. In this study, we conducted a survey
of beekeepers in Japan to examine the presence of sIgE to honey bee
venom and the number of adrenaline auto-injectors prescribed.
The participants included 113 beekeepers (104 men, 9 women;
Table 1) who were almost all staff members of private apiaries
based in Tochigi, Gunma, and Saitama prefectures, Japan. The
main work of the beekeepers is to collect honey and maintain the
breeding colonies; consequently, workers are at high risk of honey
bee stings. All participants completed questionnaires and under-
went peripheral blood tests on the same day between December
2015 and February 2016. Fifteen volunteers who had never experi-
enced a honeybee sting were enrolled as controls. The study was
approved by the Dokkyo Medical University Koshigaya Hospital
Research Ethics Committee, authorization numbers No. 1525 and
No. 1526. Written, informed consent was obtained from all partic-
ipants prior to enrollment.
The questionnaire was administered by an allergist and included
the following items: age, sex, experience of a honey bee sting (yes
or no), systemic reaction to a honey bee sting according to Mueller
grading system3 (grades I to IV) (yes or no), adrenaline auto-
injector prescription given (yes, no, unknown), and adrenaline
auto-injector carried (usually, sometimes, rarely). An adrenaline
auto-injectors were prescribed to 3 subjects with Mueller grade I
(14 subjects total), 0 in grade II (2 subjects total), 2 in grade III (3
subjects total), and 5 in grade IV (16 subjects total).
A 10-mL peripheral blood sample was collected from each
participant. Serum was immediately extracted, and sIgE antibody
(Ab) to honey bee venom was measured by Sanritsu Corporation,
Chiba, Japan. Detection of sIgE Ab by AlaSTAT 3g Allergy (AlaSTAT),
a chemiluminescent enzyme immunoassay (CLEIA), was expressedPeer review under responsibility of Japanese Society of Allergology.
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licenses/by-nc-nd/4.0/).in quantitative units (IUA/mL), with aworking range of 0.1e500 IUA/
mL. Positive results for AlaSTATwere deﬁned as values0.1 IUA/mL,
as described previously.2,4 Data are presented as means ± standard
deviation (S.D.).
Table 1 summarizes the characteristics of the beekeepers. The
quantity of sIgE to honey bee venom was 0.1 IUA/mL in 88
(77.9%) participants. Each of the 15 controls was negative for sIgE.
Since hornets hunt honey bees, beekeepers are also frequently
exposed to hornet stings, and we found sIgE (0.1 IUA/mL) to hor-
net venom in 41 participants (36.3%) (data not shown). Further-
more, antigenic cross-reactivity between honeybees and Vespula
venom is limited and largely conﬁned to hyaluronidase.5 Bee
keepers therefore also need to be aware of systemic reactions to
hornet stings. We found that adrenaline auto-injectors were pre-
scribed for 12 (10.6%) beekeepers. However, in a UK report, 18% of
British beekeepers had received prescriptions.6 Hence, compared
with British beekeepers, adrenaline auto-injectors are less
frequently prescribed to Japanese beekeepers. Among our subjects,
110 (97.3%) had experienced a honeybee sting, and a systemic reac-
tion to or positivity for honeybee venom-sIgE was seen in 35
(31.8%) and 87 (79.1%) beekeepers, respectively. Similarly, other in-
vestigators have reported that 14e35% of beekeepers have had at
least one episode of systemic allergic reaction after a bee sting.7
Moreover, 30e60% of beekeepers show honey bee venom-sIgE pos-
itivity.8 Compared with Japanese outdoor workers, 18.6% forestry
workers had experienced systemic reactions, and 62.8% showed
venom-sIgE positivity after a Hymenoptera sting.2 These results
indicate that systemic reactions and sIgE positivity to Hymenoptera
venom occur more frequently in beekeepers than in Japanese
forestry workers.
Figure 1A shows the occupations of the participants and the
number of auto-injector prescriptions given. Prescriptions were
given to 11 of 88 (12.5%) beekeepers with sIgE Ab to honey bee
venom, regardless of the presence or absence of systemic reactions,
while 4 out of 11 (36.4%) beekeepers usually carried auto-injectors.
In comparison, 71 of 214 (33.2%) Japanese forestry workers with
sIgE Ab to Hymenoptera venom were given prescriptions, and 37
of 71 (52.1%) usually carry auto-injectors.2 These results indicate
that the number of prescriptions given and the number of adrena-
line auto-injectors carried among workers with sIgE to Hymenop-
tera venom in Japan are lower in beekeepers than in forestry
workers.
Figure 1B shows that 35 beekeepers had experienced a systemic
reaction to a honey bee sting and adrenaline auto-injector prescrip-
tionswere given to 9 out of 31 (29.0%) beekeepers who showed sIgE
to honey bee venom. In contrast, prescriptions were given to 28 ofvier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
Table 1
Subject characteristics (n ¼ 113).
Beekeepers (n) 113
Sex (n)
Male (%) 104 (92.0)
Female (%) 9 (8.0)
Age (years)
10e19 1 (0.9)
20e29 1 (0.9)
30e39 13 (11.5)
40e49 11 (9.7)
50e59 14 (12.4)
60e69 44 (38.9)
70 29 (25.7)
Honey bee-sIgE (mean ± SD, n) 4.2 ± 11.1
Negative (%) 25 (22.1)
Positive (%) 88 (77.9)
Prescription of adrenaline (n)
Yes (%) 12 (10.6)
No (%) 89 (78.8)
Unknown (%) 12 (10.6)
Experience of a honey bee sting (n)
Yes (%) 110 (97.3)
No (%) 3 (2.7)
Out of beekeepers who had experienced a honey bee sting
Systemic reaction (n)
Yes (%) 35/110 (31.8)
No (%) 75/110 (68.2)
Honey bee venom-sIgE (n)
Negative (%) 23/110 (20.9)
Positive (%) 87/110 (79.1)
n, numbers; sIgE, speciﬁc IgE.
Levels of sIgE (IUA/mL) are presented as mean ± standard deviation (SD).
Interpretations of positive results are based on values  0.1 IUA/mL.
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Fig. 1. A. Numbers of prescriptions given and adrenaline auto-injectors carried by beekeepe
adrenaline auto-injectors carried by beekeepers following systemic reactions to a honey be
applicable.
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Hymenoptera stings and had sIgE to Hymenoptera venom.2 These
results indicate that among subjects who have had systemic reac-
tions and showed sIgE to Hymenoptera venom in Japan, beekeepers
are less likely to be prescribed auto-injectors than forestry workers.
In addition, only 3 of 9 (33.3%) beekeepers given prescriptions usu-
ally carry auto-injectors. Although Japanese beekeepers experience
frequent Hymenoptera stings, and often subsequent systemic reac-
tions, there appears to be a lack of awareness of potential anaphy-
laxis resulting from honey bee stings. These ﬁndings indicate that
few adrenaline auto-injectors are prescribed to Japanese bee-
keepers, and even then, auto-injectors are not usually carried. On
the other hand, the absence of sIgE to honey bee venomwas found
in 4 of the 35 (11.4%) beekeepers who had experienced systemic re-
actions to a honey bee sting. Indeed, sIgE levels decline over several
years if there are no further Hymenoptera stings and are thought to
disappear immediately after a sting.9,10 Thus, if sIgE to Hymenop-
tera venom is negative immediately after a sting, the test should
be repeated after a few weeks.
Although this was not investigated in the present study, Richter
et al. presented the ﬁrst study in the UK of bee venom allergy in
beekeepers, one of the largest to date.6 Interestingly, this study
identiﬁed that a number of factors, including having a family mem-
ber with bee venom allergy, female sex, over 2 years of beekeeping,
and premedication with antihistamines, were associated with
development of systemic reactions.6 The study also noted that
attendance at emergency departments and subsequent review by
allergy specialist was low, which is a likely explanation that only
a low proportion of beekeepers received venom immunotherapy
after a systemic reaction. As a countermeasure to anaphylaxis,sIgE
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experience of a systemic reaction, should be prescribed adrenaline
auto-injectors.2 Furthermore, beekeepers who have indeed experi-
enced a systemic reaction to a honey bee sting with sIgE Ab should
receive venom immunotherapy.11 Subjects who have experienced
an anaphylactic reaction due to honey bee stings, with negative re-
sults of sIgE to honey bee venom, also should be prescribed adren-
aline auto-injectors.
In conclusion, we found that approximately 11% of Japanese bee-
keepers with sIgE to honey bee venom and 29% who had experi-
enced systemic reactions to a honey bee sting and showed sIgE to
the venom were prescribed adrenaline auto-injectors. Moreover,
approximately 35% of beekeepers usually carry auto-injectors dur-
ing work, regardless of the presence or absence of systemic reac-
tions to honey bee stings. This study suggests that the owners of
the cooperative should consider obtaining adrenaline auto-
injector prescriptions for beekeepers who have sIgE Ab to honey
bee and/or hornet venom. In addition, beekeepers should be
educated about regularly carrying adrenalin auto-injectors.
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